Colonic Vegfa expression was found to be reduced upon neutralisation of IL-25, or genetic IL-25-deficiency, in AOM/DSS-treated mice with CAC (82), suggesting that IL-25 may promote tumour VEGF-A expression. The gene discussed is IL25; the disease is hyperinsulinemic hypoglycemia, familial, 4.